(NP (NP (ADJP-COOD (ADJP (NP (NN Vitamin) (NN D3-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ retinoic) (JJ acid-induced))) (JJ monocytic) (NN differentiation)) (: :) (NP (NP (NNS interactions)) (PP (IN between) (NP (NP (DT the) (NP-COOD (NP (JJ endogenous) (NN vitamin) (NN D3) (NN receptor)) (, ,) (NP (JJ retinoic) (NN acid) (NNS receptors)) (, ,) (CC and) (NP (NN retinoid) (NN X) (NNS receptors)))) (PP (IN in) (NP (NN U-937) (NNS cells))))) (. .)))
(S (NP-SBJ-COOD (NP (NP (JJ Retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 1,25) (NN alpha-dihydroxycholecalciferol)) (PRN (-LRB- -LRB-) (NP (NN VitD3)) (-RRB- -RRB-)))) (VP (VBP are) (NP-PRD (NP (JJ potent) (NNS regulators)) (PP (IN of) (NP (JJ hematopoletic) (NN differentiation))))) (. .))
(S (RB Yet) (, ,) (NP-SBJ-23 (JJ little)) (VP (VBZ is) (VP (VBN known) (NP (-NONE- *-23)) (PP (IN as) (TO to) (SBAR-COOD (SBAR (WHADVP-24 (WRB how)) (S (NP-SBJ (DT the) (NP-COOD (NP (NN RA)) (CC and) (NP (NN VitD3))) (NN receptor) (NN network)) (VP (VBZ operates) (PP (IN in) (NP (JJ hematopoietic) (NNS cells))) (ADVP (-NONE- *T*-24))))) (, ,) (CC and) (SBAR (IN whether) (S (NP-SBJ (NN receptor) (NNS interactions)) (VP (MD can) (VP (VB explain) (NP (NP (DT the) (NN interplay)) (PP (IN between) (NP (DT the) (ADJP-COOD (ADJP (NP (NN RA-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ VitD3-signaling))) (NNS pathways))) (PP-TMP (IN during) (NP (NN differentiation)))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NP-COOD (NP (NN expression)) (, ,) (NP (NN DNA) (NN binding)) (, ,) (CC and) (NP (JJ transcriptional) (NN activity)))) (PP (IN of) (NP (NP (DT the) (JJ endogenous) (NP-COOD (NP (NN RA)) (CC and) (NP (NN VitD3))) (NNS receptors)) (PRN (-LRB- -LCB-) (NP-COOD (NP (NP (JJ retinoic) (NN acid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNS RARs)) (-RRB- -RRB-))) (, ,) (NP (NP (NN retinoid) (NN X) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNS RXRs)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN VitD3) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN VDR)) (-RRB- -RRB-)))) (-RRB- -RCB-)))) (PP (IN in) (NP (NP (DT the) (NN U-937) (NN cell) (NN line)) (, ,) (SBAR (WHPP-25 (IN in) (WHNP (WDT which))) (S (NP-SBJ-COOD (NP (NN RA)) (CC and) (NP (NN VitD3))) (VP (VBP induce) (NP (JJ distinct) (JJ monocytic) (NN differentiation) (NNS pathways)) (PP (-NONE- *T*-25))))))))) (. .))
(S (NP-SBJ (NN VitD3) (NN induction)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NN (RXR VDR)) (JJ DNA-binding) (NNS complexes))) (PP (IN on) (NP-COOD (CC both) (NP (NN VitD3) (NN response) (NNS elements)) (CC and) (NP (NP (NN RA) (NN response) (NNS elements)) (PRN (-LRB- -LRB-) (NP (NNS RAREs)) (-RRB- -RRB-)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-26 (JJ transcriptional) (NN activation)) (VP (VBD was) (VP (ADVP (RB only)) (VBN observed) (NP (-NONE- *-26)) (PP (IN from) (NP (DT a) (ADJP (NN VitD3) (NN response) (JJ element-driven)) (NN reporter) (NN construct))))) (. .))
(S (NP-SBJ-27 (JJ Several) (JJ DNA-binding) (NNS complexes)) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-27)) (PP (IN on) (NP (NP (NNS RAREs)) (PP (IN in) (NP (JJ undifferentiated) (NNS cells))))))) (. .))
(S (NP-SBJ (NP (NN Stimulation)) (PP (IN by) (NP (NN RA)))) (VP (VBD resulted) (PP (IN in) (NP-COOD (NP (VBN increased) (ADJP (NN RAR) (NN (RXR beta))) (NN DNA) (NN binding)) (, ,) (NP (VBN activated) (JJ RARE-dependent) (NN transcription)) (, ,) (CC and) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NN RAR-beta))))))) (. .))
(S (NP-SBJ-28 (NP (JJ Concomitant) (NN stimulation)) (PP (IN by) (NP (NN VitD3)))) (VP (VBD inhibited) (NP (NP (DT the) (JJ RA-stimulated) (NN formation)) (PP (IN of) (NP (ADJP (NN RAR) (NN (RXR beta))) (NNS heterodimers)))) (, ,) (S (NP-SBJ (-NONE- *-28)) (VP (VBG favoring) (NP (NP (NN (RXR VDR)) (NN binding)) (PP (TO to) (NP (DT the) (NN RARE))))))) (. .))
(S (ADVP (RB Also)) (, ,) (NP-SBJ (NN VitD3)) (VP (VBD inhibited) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NN CD23)) (CC and) (NP (NN CD49f))) (, ,) (NP (NP (JJ characteristic) (NNS markers)) (PP (IN of) (NP (JJ retinoid-induced) (NN U-937) (NN cell) (NN differentiation)))))))) (. .))
(S (IN In) (NP (NN contrast)) (, ,) (NP-SBJ-COOD-29 (CC neither) (NP (DT the) (ADJP-COOD (ADJP (JJ RA-stimulated)) (, ,) (ADJP (JJ RARE-mediated))) (NN transcription)) (CC nor) (NP (DT the) (VBN induced) (NN RAR-beta) (NN expression))) (VP (VBD was) (VP (VBN suppressed) (NP (-NONE- *-29)) (PP (IN by) (NP-LGS (NN VitD3))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN VitD3)) (ADVP (RB selectively)) (VP (VBD inhibited) (NP-COOD (NP (DT the) (JJ retinoid-induced) (NN differentiation) (NN program)) (CONJP (CC but) (RB not)) (NP (DT the) (JJ RARE-mediated) (NN signal)))))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP-COOD (VP (VBP demonstrate) (NP (NP (DT a) (JJ complex) (NN role)) (PP (IN for) (NP (NN VitD3))) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG modifying) (NP (DT the) (NN retinoid) (NN differentiation) (NN pathway))))))) (CC and) (VP (MD may) (VP (VB have) (NP (NP (NNS implications)) (PP (IN for) (NP (NP (JJ differentiation-inducing) (NN therapy)) (PP (IN of) (NP (JJ hematopoietic) (NNS tumors))))))))) (. .))
